Trials / Completed
CompletedNCT02996240
Breast, Omega 3 Free Fatty Acid, Ph 0
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Breast Cancer (CTMS# 16-0119)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Assess the impact of dietary omega 3 free fatty acids breast cancer patients.
Detailed description
Prospective, single arm, short term study with correlative biomarker endpoints. Two hundred (200) newly diagnosed breast cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker evaluation study prior to surgical resection. Patients will be receive fish Oil (Omega-3 FFAs, 2700 mg by mouth twice daily).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 FFA | Omega-3 Free Fatty Acid will be given as a fish oil in a capsule. |
Timeline
- Start date
- 2017-06-12
- Primary completion
- 2019-09-27
- Completion
- 2021-02-22
- First posted
- 2016-12-19
- Last updated
- 2021-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02996240. Inclusion in this directory is not an endorsement.